Literature DB >> 2592563

Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum.

H Moncayo1, R Moncayo, R Benz, A Wolf, C Lauritzen.   

Abstract

We developed an ELISA system for the detection of human anti-ovarian antibodies. Bovine corpora lutea were extracted in PBS (pH 7.2) and fractionated by ultracentrifugation. Both the soluble fraction obtained after 80,000 g (S80) and the Triton-extracted membrane fraction (ST288) were used as antigens. Additionally, the luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor was isolated by affinity chromatography (wheat germ agglutinin and LH-Sepharose) and also used as an antigen. In 7 of 14 patients with primary sterility and endometriosis a positive reaction was observed. Similarly, 6 of 16 patients with secondary sterility and endometriosis were also positive. Patients being stimulated for in vitro fertilization and presenting either primary or secondary sterility were positive in 5 of 22 and 6 of 16 cases, respectively. In the S80 test 41 of 60 sera presented IgG2 antibodies, whereas in the ST288 test 38 of 60 belonged to the IgG1 subclass. Kappa and lambda chains were equally distributed. Some patients could recognize the unoccupied LH/hCG receptor as an antigen, while others recognized only the complex formed by the hormone plus the hormone receptor. The S80 and ST288 antigens were isolated by affinity chromatography. Gel permeation of the purified antigens revealed in each case the presence of an antigen complex. The apparent molecular weight was between 2,000 and 36,000 D. Cross-reactivity studies using affinity-purified antibodies demonstrated an antigenic relationship of the membrane, soluble, and extractable fractions. NAc-(beta-1----4)-D-glucosaminide and -D-galactopyranoside were the main terminal glycosides.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592563      PMCID: PMC304065          DOI: 10.1172/JCI114372

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Circulating antiovarian antibodies in premature ovarian failure.

Authors:  M M Alper; P R Garner
Journal:  Obstet Gynecol       Date:  1987-07       Impact factor: 7.661

2.  Ovarian failure and antiovarian antibodies in association with hypoparathyroidism, moniliasis, and Addison's and Hashimoto's diseases.

Authors:  A M Vazquez; F M Kenny
Journal:  Obstet Gynecol       Date:  1973-03       Impact factor: 7.661

3.  Autoimmunity and ovarian failure.

Authors:  M de Moraes Ruehsen; R M Blizzard; R Garcia-Bunuel; G S Jones
Journal:  Am J Obstet Gynecol       Date:  1972-03       Impact factor: 8.661

Review 4.  Human immunoglobulins: classes, subclasses, genetic variants, and idiotypes.

Authors:  J B Natvig; H G Kunkel
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

5.  Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease.

Authors:  W J Irvine; M M Chan; L Scarth; F O Kolb; M Hartog; R I Bayliss; M I Drury
Journal:  Lancet       Date:  1968-10-26       Impact factor: 79.321

6.  The cytotoxic effect of serum from patients with Addison's disease and autoimmune ovarian failure on human granulosa cells in culture.

Authors:  K P McNatty; R V Short; E W Barnes; W J Irvine
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

7.  Circulating antiovarian antibodies in premature ovarian failure.

Authors:  M D Damewood; H A Zacur; G J Hoffman; J A Rock
Journal:  Obstet Gynecol       Date:  1986-12       Impact factor: 7.661

8.  Organ-specific antibodies against ovary in patients with systemic lupus erythematosus.

Authors:  H Moncayo-Naveda; R Moncayo; R Benz; A Wolf; C Lauritzen
Journal:  Am J Obstet Gynecol       Date:  1989-05       Impact factor: 8.661

9.  Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure.

Authors:  P Ahonen; A Miettinen; J Perheentupa
Journal:  J Clin Endocrinol Metab       Date:  1987-03       Impact factor: 5.958

10.  Islet cell antigens. Extraction studies and ELISA analysis.

Authors:  R Moncayo; K Kirsch; T Pasquarello; E F Pfeiffer
Journal:  Diabetes       Date:  1988-08       Impact factor: 9.461

View more
  11 in total

1.  Antiovarian antibodies in primary Sjogren's syndrome.

Authors:  Kyriaki Euthymiopoulou; Alexios J Aletras; Panagiota Ravazoula; Anna Niarakis; Dimitris Daoussis; Ioannis Antonopoulos; Stamatis-Nick Liossis; Andrew P Andonopoulos
Journal:  Rheumatol Int       Date:  2007-05-31       Impact factor: 2.631

Review 2.  Fertility and pregnancy in women with primary adrenal insufficiency.

Authors:  Sophie Bensing; Roberta Giordano; Alberto Falorni
Journal:  Endocrine       Date:  2020-05-29       Impact factor: 3.633

3.  Detection of antibodies to ovarian antigens in women with premature ovarian failure.

Authors:  N J Wheatcroft; A A Toogood; T C Li; I D Cooke; A P Weetman
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

4.  Antiovarian antibodies and their effect on the outcome of assisted reproduction.

Authors:  M Narayanan; P S Murthy; S A Munaf; L C Shah; M D Kini
Journal:  J Assist Reprod Genet       Date:  1995-10       Impact factor: 3.412

5.  Analysis of the serum reproductive system related autoantibodies of infertility patients in Tianjin region of China.

Authors:  Yan Huo; Yanying Xu; Jianmei Wang; Fang Wang; Yu Liu; Yujuan Zhang; Bumei Zhang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 6.  A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency.

Authors:  A Falorni; V Minarelli; C M Eads; C M Joachim; L Persani; R Rossetti; P Yurttas Beim; V A Pellegrini; P F Schnatz; S Rafique; K Kissell; K A Calis; V Popat; L M Nelson
Journal:  Panminerva Med       Date:  2014-10-07       Impact factor: 5.197

Review 7.  Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).

Authors:  Bunpei Ishizuka
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

8.  Does ovarian autoimmunity play a role in the pathophysiology of premature ovarian insufficiency?

Authors:  Vrinda Khole
Journal:  J Midlife Health       Date:  2010-01

Review 9.  Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone.

Authors:  Kadri Haller-Kikkatalo; Andres Salumets; Raivo Uibo
Journal:  Clin Dev Immunol       Date:  2011-10-05

Review 10.  Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach.

Authors:  Nadja Tariverdian; Theoharis C Theoharides; Friederike Siedentopf; Gabriela Gutiérrez; Udo Jeschke; Gabriel A Rabinovich; Sandra M Blois; Petra C Arck
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.